Chromosomal tethering and proviral integration

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1799, Issue 3-4, 2010, Pages 207-216

  Delelis, Olivier ^a   Zamborlini, Alessia ^b   Thierry, Sylvain ^a   Saïb, Ali ^b,c  

^a Ecole Normale Superieure de Cachan   (France)

^b Institut Universitaire d'Hématologie   (France)

^c Bioinformatique et Chimie Moléculaire   (France)

Author keywords

Complex; HIV 1; Integrase; Lentiviruses; Pre integration; Retrotransposon; Viral integration

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; BARRIER TO AUTOINTEGRATION FACTOR; COMPLEMENTARY DNA; GAG PROTEIN; INTEGRASE; LENS EPITHELIUM DERIVED GROWTH FACTOR; NUCLEOPROTEIN; STRUCTURAL PROTEIN; VIRUS DNA; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

CELL ADHESION; CELL MIGRATION; CELL SPECIFICITY; CHROMATIN STRUCTURE; CHROMOSOMAL TETHERING; CHROMOSOME; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME STRUCTURE; HERPES VIRUS; HOST CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KAPOSI SARCOMA; MOLECULAR MECHANICS; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROVIRUS; RETROPOSON; RETROVIRUS; REVERSE TRANSCRIPTION; REVIEW; RNA TUMOR VIRUS; SEQUENCE ANALYSIS; TARGET CELL; VIRUS DNA CELL DNA INTERACTION; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS GENOME; VIRUS REPLICATION; YEAST;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77949298620     PISSN: 18749399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2009.08.005     Document Type: Review

References (162)

1. Agapkina J., Smolov M., Barbe S., Zubin E., Zatsepin T., Deprez E., Le Bret M., Mouscadet J.F., and Gottikh M. Probing of HIV-1 integrase/DNA interactions using novel analogs of viral DNA. J. Biol. Chem. 281 (2006) 11530-11540
2. Arhel N.J., Souquere-Besse S., Munier S., Souque P., Guadagnini S., Rutherford S., Prevost M.C., Allen T.D., and Charneau P. HIV-1 DNA Flap formation promotes uncoating of the pre-integration complex at the nuclear pore. EMBO J. 26 (2007) 3025-3037
3. Barbera A.J., Ballestas M.E., and Kaye K.M. The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 N terminus is essential for chromosome association, DNA replication, and episome persistence. J. Virol. 78 (2004) 294-301
4. Barbera A.J., Chodaparambil J.V., Kelley-Clarke B., Luger K., and Kaye K.M. Kaposi's sarcoma-associated herpesvirus LANA hitches a ride on the chromosome. Cell Cycle 5 (2006) 1048-1052
5. Behrens R., Hayles J., and Nurse P. Fission yeast retrotransposon Tf1 integration is targeted to 5′ ends of open reading frames. Nucleic Acids Res. 28 (2000) 4709-4716
6. Boeke J.D., and Devine S.E. Yeast retrotransposons: finding a nice quiet neighborhood. Cell 93 (1998) 1087-1089
7. Botbol Y., Raghavendra N.K., Rahman S., Engelman A., and Lavigne M. Chromatinized templates reveal the requirement for the LEDGF/p75 PWWP domain during HIV-1 integration in vitro. Nucleic Acids Res. 36 (2008) 1237-1246
8. Bouchet N., Bischerour J., Germon S., Guillard J., Dubernet M., Viaud-Massuard M.C., Delelis O., Ryabinin V., Bigot Y., and Auge-Gouillou C. First mariner mos1 transposase inhibitors. Mini. Rev. Med. Chem. 9 (2009) 431-439
9. Bouyac-Bertoia M., Dvorin J.D., Fouchier R.A., Jenkins Y., Meyer B.E., Wu L.I., Emerman M., and Malim M.H. HIV-1 infection requires a functional integrase NLS. Mol. Cell 7 (2001) 1025-1035
10. Brady T.L., Fuerst P.G., Dick R.A., Schmidt C., and Voytas D.F. Retrotransposon target site selection by imitation of a cellular protein. Mol. Cell Biol. 28 (2008) 1230-1239
11. Brass A.L., Dykxhoorn D.M., Benita Y., Yan N., Engelman A., Xavier R.J., Lieberman J., and Elledge S.J. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319 (2008) 921-926
12. Brown P.O., Bowerman B., Varmus H.E., and Bishop J.M. Retroviral integration: structure of the initial covalent product and its precursor, and a role for the viral IN protein. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 2525-2529
13. Brussel A., and Sonigo P. Evidence for gene expression by unintegrated human immunodeficiency virus type 1 DNA species. J. Virol. 78 (2004) 11263-11271
14. Bukrinsky M.I., Sharova N., Dempsey M.P., Stanwick T.L., Bukrinskaya A.G., Haggerty S., and Stevenson M. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 6580-6584
15. Bukrinsky M.I., Sharova N., McDonald T.L., Pushkarskaya T., Tarpley W.G., and Stevenson M. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 6125-6129
16. Bushman F.D. Tethering human immunodeficiency virus 1 integrase to a DNA site directs integration to nearby sequences. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 9233-9237
17. Bushman F.D. Retroviral integration and human gene therapy. J. Clin. Invest. 117 (2007) 2083-2086
18. Busschots K., Vercammen J., Emiliani S., Benarous R., Engelborghs Y., Christ F., and Debyser Z. The interaction of LEDGF/p75 with integrase is lentivirus-specific and promotes DNA binding. J. Biol. Chem. 280 (2005) 17841-17847
19. Carteau S., Gorelick R.J., and Bushman F.D. Coupled integration of human immunodeficiency virus type 1 cDNA ends by purified integrase in vitro: stimulation by the viral nucleocapsid protein. J. Virol. 73 (1999) 6670-6679
20. Carteau S., Hoffmann C., and Bushman F. Chromosome structure and human immunodeficiency virus type 1 cDNA integration: centromeric alphoid repeats are a disfavored target. J. Virol. 72 (1998) 4005-4014
21. Casacuberta E., and Pardue M.L. Coevolution of the telomeric retrotransposons across Drosophila species. Genetics 161 (2002) 1113-1124
22. Casacuberta E., and Pardue M.L. Transposon telomeres are widely distributed in the Drosophila genus: TART elements in the virilis group. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 3363-3368
23. Cavazzana-Calvo M., Hacein-Bey S., de Saint B.G., Gross F., Yvon E., Nusbaum P., Selz F., Hue C., Certain S., Casanova J.L., Bousso P., Deist F.L., and Fischer A. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288 (2000) 669-672
24. Cavazzana-Calvo M., Thrasher A., and Mavilio F. The future of gene therapy. Nature 427 (2004) 779-781
25. Chalker D.L., and Sandmeyer S.B. Ty3 integrates within the region of RNA polymerase III transcription initiation. Genes Dev. 6 (1992) 117-128
26. Chalker D.L., and Sandmeyer S.B. Sites of RNA polymerase III transcription initiation and Ty3 integration at the U6 gene are positioned by the TATA box. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 4927-4931
27. Chatterjee A.G., Leem Y.E., Kelly F.D., and Levin H.L. The chromodomain of Tf1 integrase promotes binding to cDNA and mediates target site selection. J. Virol. 83 6 (2009 Mar) 2675-2685 Epub 2008 Dec 24
28. Chen H., and Engelman A. The barrier-to-autointegration protein is a host factor for HIV type 1 integration. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15270-15274
29. Cherepanov P. LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro. Nucleic Acids Res. 35 (2007) 113-124
30. Cherepanov P., Maertens G., Proost P., Devreese B., Van Beeumen J., Engelborghs Y., De Clercq E., and Debyser Z. HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J. Biol. Chem. 278 (2003) 372-381
31. Cherepanov P., Sun Z.Y., Rahman S., Maertens G., Wagner G., and Engelman A. Solution structure of the HIV-1 integrase-binding domain in LEDGF/p75. Nat. Struct. Mol. Biol. 12 (2005) 526-532
32. Chow S.A., Vincent K.A., Ellison V., and Brown P.O. Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science 255 (1992) 723-726
33. Christ F., Thys W., De R.J., Gijsbers R., Albanese A., Arosio D., Emiliani S., Rain J.C., Benarous R., Cereseto A., and Debyser Z. Transportin-SR2 imports HIV into the nucleus. Curr. Biol. 18 (2008) 1192-1202
34. Ciuffi A., and Bushman F.D. Retroviral DNA integration: HIV and the role of LEDGF/p75. Trends Genet. 22 (2006) 388-395
35. Ciuffi A., Diamond T.L., Hwang Y., Marshall H.M., and Bushman F.D. Modulating target site selection during human immunodeficiency virus DNA integration in vitro with an engineered tethering factor. Hum. Gene Ther. 17 (2006) 960-967
36. Ciuffi A., Diamond T.L., Hwang Y., Marshall H.M., and Bushman F.D. Modulating target site selection during human immunodeficiency virus DNA integration in vitro with an engineered tethering factor. Hum. Gene Ther. (2006)
37. Craigie R. Hotspots and warm spots: integration specificity of retroelements. Trends Genet. 8 (1992) 187-190
38. Cullen B.R. Journey to the center of the cell. Cell 105 (2001) 697-700
39. Dai J., Xie W., Brady T.L., Gao J., and Voytas D.F. Phosphorylation regulates integration of the yeast Ty5 retrotransposon into heterochromatin. Mol. Cell 27 (2007) 289-299
40. Delelis O., Carayon K., Guiot E., Leh H., Tauc P., Brochon J.C., Mouscadet J.F., and Deprez E. Insight into the integrase-DNA recognition mechanism. A specific DNA-binding mode revealed by an enzymatically labeled integrase. J. Biol. Chem. 283 (2008) 27838-27849
41. Delelis O., Carayon K., Saib A., Deprez E., and Mouscadet J.F. Integrase and integration: biochemical activities of HIV-1 integrase. Retrovirology 5 (2008) 114
42. Delelis O., Lehmann-Che J., and Saib A. Foamy viruses-a world apart. Curr. Opin. Microbiol. 7 (2004) 400-406
43. Delelis O., Parissi V., Leh H., Mbemba G., Petit C., Sonigo P., Deprez E., and Mouscadet J.F. Efficient and specific internal cleavage of a retroviral palindromic DNA sequence by tetrameric HIV-1 integrase. PLoS ONE 2 (2007) e608
44. Delelis O., Petit C., Leh H., Mbemba G., Mouscadet J.F., and Sonigo P. A novel function for spumaretrovirus integrase: an early requirement for integrase-mediated cleavage of 2 LTR circles. Retrovirology 2 (2005) 31
45. Delelis O., Saib A., and Sonigo P. Biphasic DNA synthesis in spumaviruses. J. Virol. 77 (2003) 8141-8146
46. Derse D., Crise B., Li Y., Princler G., Lum N., Stewart C., McGrath C.F., Hughes S.H., Munroe D.J., and Wu X. Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses. J. Virol. 81 (2007) 6731-6741
47. Devine S.E., and Boeke J.D. Integration of the yeast retrotransposon Ty1 is targeted to regions upstream of genes transcribed by RNA polymerase III. Genes Dev. 10 (1996) 620-633
48. Dvorin J.D., Bell P., Maul G.G., Yamashita M., Emerman M., and Malim M.H. Reassessment of the roles of integrase and the central DNA flap in human immunodeficiency virus type 1 nuclear import. J. Virol. 76 (2002) 12087-12096
49. Esposito D., and Craigie R. Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction. EMBO J. 17 (1998) 5832-5843
50. Fassati A., and Goff S.P. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J. Virol. 75 (2001) 3626-3635
51. Faure A., Calmels C., Desjobert C., Castroviejo M., Caumont-Sarcos A., Tarrago-Litvak L., Litvak S., and Parissi V. HIV-1 integrase crosslinked oligomers are active in vitro. Nucleic Acids Res. 33 (2005) 977-986
52. Faye B., Arnaud F., Peyretaillade E., Brasset E., Dastugue B., and Vaury C. Functional characteristics of a highly specific integrase encoded by an LTR-retrotransposon. PLoS ONE 3 (2008) e3185
53. Gai X., and Voytas D.F. A single amino acid change in the yeast retrotransposon Ty5 abolishes targeting to silent chromatin. Mol. Cell 1 (1998) 1051-1055
54. Gallay P., Hope T., Chin D., and Trono D. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 9825-9830
55. Gasser S.M., and Cockell M.M. The molecular biology of the SIR proteins. Gene 279 (2001) 1-16
56. Geiduschek E.P., and Kassavetis G.A. The RNA polymerase III transcription apparatus. J. Mol. Biol. 310 (2001) 1-26
57. Gelderblom H.C., Vatakis D.N., Burke S.A., Lawrie S.D., Bristol G.C., and Levy D.N. Viral complementation allows HIV-1 replication without integration. Retrovirology 5 (2008) 60
58. Goldgur Y., Dyda F., Hickman A.B., Jenkins T.M., Craigie R., and Davies D.R. Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9150-9154
59. Goujon C., Arfi V., Pertel T., Luban J., Lienard J., Rigal D., Darlix J.L., and Cimarelli A. Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells. J. Virol. 82 (2008) 12335-12345
60. Grandgenett D.P. Symmetrical recognition of cellular DNA target sequences during retroviral integration. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 5903-5904
61. Guiot E., Carayon K., Delelis O., Simon F., Tauc P., Zubin E., Gottikh M., Mouscadet J.F., Brochon J.C., and Deprez E. Relationship between the oligomeric status of HIV-1 integrase on DNA and enzymatic activity. J. Biol. Chem. 281 (2006) 22707-22719
62. Hacein-Bey-Abina S., Von K.C., Schmidt M., Le D.F., Wulffraat N., McIntyre E., Radford I., Villeval J.L., Fraser C.C., Cavazzana-Calvo M., and Fischer A. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348 (2003) 255-256
63. Hacein-Bey-Abina S., Von K.C., Schmidt M., McCormack M.P., Wulffraat N., Leboulch P., Lim A., Osborne C.S., Pawliuk R., Morillon E., Sorensen R., Forster A., Fraser P., Cohen J.I., de Saint B.G., Alexander I., Wintergerst U., Frebourg T., Aurias A., Stoppa-Lyonnet D., Romana S., Radford-Weiss I., Gross F., Valensi F., Delabesse E., Macintyre E., Sigaux F., Soulier J., Leiva L.E., Wissler M., Prinz C., Rabbitts T.H., Le D.F., Fischer A., and Cavazzana-Calvo M. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302 (2003) 415-419
64. Harris D., and Engelman A. Both the structure and DNA binding function of the barrier-to-autointegration factor contribute to reconstitution of HIV type 1 integration in vitro. J. Biol. Chem. 275 (2000) 39671-39677
65. Hatziioannou T., and Goff S.P. Infection of nondividing cells by Rous sarcoma virus. J. Virol. 75 (2001) 9526-9531
66. Holman A.G., and Coffin J.M. Symmetrical base preferences surrounding HIV-1, avian sarcoma/leukosis virus, and murine leukemia virus integration sites. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 6103-6107
67. Holmes-Son M.L., and Chow S.A. Integrase-lexA fusion proteins incorporated into human immunodeficiency virus type 1 that contains a catalytically inactive integrase gene are functional to mediate integration. J. Virol. 74 (2000) 11548-11556
68. Ibarrondo F.J., Choi R., Geng Y.Z., Canon J., Rey O., Baldwin G.C., and Krogstad P. HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. AIDS Res. Hum. Retrovir. 17 (2001) 1489-1500
69. Ji H., Moore D.P., Blomberg M.A., Braiterman L.T., Voytas D.F., Natsoulis G., and Boeke J.D. Hotspots for unselected Ty1 transposition events on yeast chromosome III are near tRNA genes and LTR sequences. Cell 73 (1993) 1007-1018
70. Kelly J., Beddall M.H., Yu D., Iyer S.R., Marsh J.W., and Wu Y. Human macrophages support persistent transcription from unintegrated HIV-1 DNA. Virology 372 (2008) 300-312
71. Kim J.M., Vanguri S., Boeke J.D., Gabriel A., and Voytas D.F. Transposable elements and genome organization: a comprehensive survey of retrotransposons revealed by the complete Saccharomyces cerevisiae genome sequence. Genome Res. 8 (1998) 464-478
72. Kimpton J., and Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 66 (1992) 2232-2239
73. Kirchner J., Connolly C.M., and Sandmeyer S.B. Requirement of RNA polymerase III transcription factors for in vitro position-specific integration of a retroviruslike element. Science 267 (1995) 1488-1491
74. Konig R., Zhou Y., Elleder D., Diamond T.L., Bonamy G.M., Irelan J.T., Chiang C.Y., Tu B.P., De Jesus P.D., Lilley C.E., Seidel S., Opaluch A.M., Caldwell J.S., Weitzman M.D., Kuhen K.L., Bandyopadhyay S., Ideker T., Orth A.P., Miraglia L.J., Bushman F.D., Young J.A., and Chanda S.K. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135 (2008) 49-60
75. Leblanc P., Dastugue B., and Vaury C. The integration machinery of ZAM, a retroelement from Drosophila melanogaster, acts as a sequence-specific endonuclease. J. Virol. 73 (1999) 7061-7064
76. Leblanc P., Desset S., Dastugue B., and Vaury C. Invertebrate retroviruses: ZAM a new candidate in D.melanogaster. EMBO J. 16 (1997) 7521-7531
77. Lee S.P., Xiao J., Knutson J.R., Lewis M.S., and Han M.K. Zn2+ promotes the self-association of human immunodeficiency virus type-1 integrase in vitro. Biochemistry 36 (1997) 173-180
78. Leem Y.E., Ripmaster T.L., Kelly F.D., Ebina H., Heincelman M.E., Zhang K., Grewal S.I., Hoffman C.S., and Levin H.L. Retrotransposon Tf1 is targeted to Pol II promoters by transcription activators. Mol. Cell 30 (2008) 98-107
79. Lehmann-Che J., Giron M.L., Delelis O., Lochelt M., Bittoun P., Tobaly-Tapiero J., De T.H., and Saib A. Protease-dependent uncoating of a complex retrovirus. J. Virol. 79 (2005) 9244-9253
80. Lesage P., and Todeschini A.L. Happy together: the life and times of Ty retrotransposons and their hosts. Cytogenet. Genome Res. 110 (2005) 70-90
81. Levis R.W., Ganesan R., Houtchens K., Tolar L.A., and Sheen F.M. Transposons in place of telomeric repeats at a Drosophila telomere. Cell 75 (1993) 1083-1093
82. Lewinski M.K., Yamashita M., Emerman M., Ciuffi A., Marshall H., Crawford G., Collins F., Shinn P., Leipzig J., Hannenhalli S., Berry C.C., Ecker J.R., and Bushman F.D. Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog. 2 (2006) e60
83. Li L., Yoder K., Hansen M.S., Olvera J., Miller M.D., and Bushman F.D. Retroviral cDNA integration: stimulation by HMG I family proteins. J. Virol. 74 (2000) 10965-10974
84. Li M., and Craigie R. Processing of viral DNA ends channels the HIV-1 integration reaction to concerted integration. J. Biol. Chem. 280 (2005) 29334-29339
85. Li M., Mizuuchi M., Burke Jr. T.R., and Craigie R. Retroviral DNA integration: reaction pathway and critical intermediates. EMBO J. 25 (2006) 1295-1304
86. Limon A., Devroe E., Lu R., Ghory H.Z., Silver P.A., and Engelman A. Nuclear localization of human immunodeficiency virus type 1 preintegration complexes (PICs): V165A and R166A are pleiotropic integrase mutants primarily defective for integration, not PIC nuclear import. J. Virol. 76 (2002) 10598-10607
87. Lin C.W., and Engelman A. The barrier-to-autointegration factor is a component of functional human immunodeficiency virus type 1 preintegration complexes. J. Virol. 77 (2003) 5030-5036
88. Liu B., Dai R., Tian C.J., Dawson L., Gorelick R., and Yu X.F. Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. J. Virol. 73 (1999) 2901-2908
89. Llano M., Delgado S., Vanegas M., and Poeschla E.M. Lens epithelium-derived growth factor/p75 prevents proteasomal degradation of HIV-1 integrase. J. Biol. Chem. 279 (2004) 55570-55577
90. Llano M., Vanegas M., Fregoso O., Saenz D., Chung S., Peretz M., and Poeschla E.M. LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes. J. Virol. 78 (2004) 9524-9537
91. Lori F., di, V M., de Vico A.L., Lusso P., Reitz Jr. M.S., and Gallo R.C. Viral DNA carried by human immunodeficiency virus type 1 virions. J. Virol. 66 (1992) 5067-5074
92. Maignan S., Guilloteau J.P., Zhou-Liu Q., Clement-Mella C., and Mikol V. Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: high level of similarity of the active site with other viral integrases. J. Mol. Biol. 282 (1998) 359-368
93. Maroun M., Delelis O., Coadou G., Bader T., Segeral E., Mbemba G., Petit C., Sonigo P., Rain J.C., Mouscadet J.F., Benarous R., and Emiliani S. Inhibition of early steps of HIV-1 replication by SNF5/Ini1. J. Biol. Chem. 281 (2006) 22736-22743
94. Marshall H.M., Ronen K., Berry C., Llano M., Sutherland H., Saenz D., Bickmore W., Poeschla E., and Bushman F.D. Role of PSIP1/LEDGF/p75 in lentiviral infectivity and integration targeting. PLoS ONE 2 (2007) e1340
95. Masson C., Bury-Mone S., Guiot E., Saez-Cirion A., Schoevaert-Brossault D., Brachet-Ducos C., Delelis O., Subra F., Jeanson-Leh L., and Mouscadet J.F. Ku80 participates in the targeting of retroviral transgenes to the chromatin of CHO cells. J. Virol. 81 (2007) 7924-7932
96. Maxwell P.H., and Curcio M.J. Host factors that control long terminal repeat retrotransposons in Saccharomyces cerevisiae: implications for regulation of mammalian retroviruses. Eukaryot. Cell 6 (2007) 1069-1080
97. Maxwell P.H., and Curcio M.J. Host factors that control long terminal repeat retrotransposons in Saccharomyces cerevisiae: implications for regulation of mammalian retroviruses. Eukaryot. Cell 6 (2007) 1069-1080
98. McBride A.A., McPhillips M.G., and Oliveira J.G. Brd4: tethering, segregation and beyond. Trends Microbiol. 12 (2004) 527-529
99. McDonald D., Vodicka M.A., Lucero G., Svitkina T.M., Borisy G.G., Emerman M., and Hope T.J. Visualization of the intracellular behavior of HIV in living cells. J. Cell Biol. 159 (2002) 441-452
100. McKee C.J., Kessl J.J., Shkriabai N., Dar M.J., Engelman A., and Kvaratskhelia M. Dynamic modulation of HIV-1 integrase structure and function by cellular lens epithelium-derived growth factor (LEDGF) protein. J. Biol. Chem. 283 (2008) 31802-31812
101. Miller M.D., Farnet C.M., and Bushman F.D. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J. Virol. 71 (1997) 5382-5390
102. Mitchell R.S., Beitzel B.F., Schroder A.R., Shinn P., Chen H., Berry C.C., Ecker J.R., and Bushman F.D. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2 (2004) E234
103. Mooslehner K., Karls U., and Harbers K. Retroviral integration sites in transgenic Mov mice frequently map in the vicinity of transcribed DNA regions. J. Virol. 64 (1990) 3056-3058
104. Naghavi M.H., and Goff S.P. Retroviral proteins that interact with the host cell cytoskeleton. Curr. Opin. Immunol. 19 (2007) 402-407
105. Narezkina A., Taganov K.D., Litwin S., Stoyanova R., Hayashi J., Seeger C., Skalka A.M., and Katz R.A. Genome-wide analyses of avian sarcoma virus integration sites. J. Virol. 78 (2004) 11656-11663
106. Nisole S., and Saib A. Early steps of retrovirus replicative cycle. Retrovirology 1 (2004) 9
107. Nowrouzi A., Dittrich M., Klanke C., Heinkelein M., Rammling M., Dandekar T., Von K.C., and Rethwilm A. Genome-wide mapping of foamy virus vector integrations into a human cell line. J. Gen. Virol. 87 (2006) 1339-1347
108. Pandey K.K., Sinha S., and Grandgenett D.P. Transcriptional co-activator LEDGF/p75 modulates HIV-1 integrase mediated concerted integration. J. Virol. 81 8 (2007 Apr) 3969-3979 Epub 2007 Jan 31
109. Pardue M.L., and DeBaryshe P.G. Retrotransposons provide an evolutionarily robust non-telomerase mechanism to maintain telomeres. Annu. Rev. Genet. 37 (2003) 485-511
110. Patton G.S., Erlwein O., and McClure M.O. Cell-cycle dependence of foamy virus vectors. J. Gen. Virol. 85 (2004) 2925-2930
111. Petit C., Giron M.L., Tobaly-Tapiero J., Bittoun P., Real E., Jacob Y., Tordo N., De T.H., and Saib A. Targeting of incoming retroviral Gag to the centrosome involves a direct interaction with the dynein light chain 8. J. Cell Sci. 116 (2003) 3433-3442
112. Petitjean G., Al T.Y., Tuaillon E., Mettling C., Baillat V., Reynes J., Segondy M., and Vendrell J.P. Unintegrated HIV-1 provides an inducible and functional reservoir in untreated and highly active antiretroviral therapy-treated patients. Retrovirology 4 (2007) 60
113. Piatak Jr. M., Saag M.S., Yang L.C., Clark S.J., Kappes J.C., Luk K.C., Hahn B.H., Shaw G.M., and Lifson J.D. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259 (1993) 1749-1754
114. Ploubidou A., and Way M. Viral transport and the cytoskeleton. Curr. Opin. Cell Biol. 13 (2001) 97-105
115. Pruss D., Bushman F.D., and Wolffe A.P. Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 5913-5917
116. Pruss D., Reeves R., Bushman F.D., and Wolffe A.P. The influence of DNA and nucleosome structure on integration events directed by HIV integrase. J. Biol. Chem. 269 (1994) 25031-25041
117. Pryciak P.M., and Varmus H.E. Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection. Cell 69 (1992) 769-780
118. Rashkova S., Athanasiadis A., and Pardue M.L. Intracellular targeting of Gag proteins of the Drosophila telomeric retrotransposons. J. Virol. 77 (2003) 6376-6384
119. Rashkova S., Karam S.E., Kellum R., and Pardue M.L. Gag proteins of the two Drosophila telomeric retrotransposons are targeted to chromosome ends. J. Cell Biol. 159 (2002) 397-402
120. Risco C., Menendez-Arias L., Copeland T.D., da Pinto S.P., and Oroszlan S. Intracellular transport of the murine leukemia virus during acute infection of NIH 3 T3 cells: nuclear import of nucleocapsid protein and integrase. J. Cell Sci. 108 Pt 9 (1995) 3039-3050
121. Sandmeyer S. Targeting transposition: at home in the genome. Genome Res. 8 (1998) 416-418
122. Sandmeyer S. Integration by design. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 5586-5588
123. Sandmeyer S.B. Yeast retrotransposons. Curr. Opin. Genet. Dev. 2 (1992) 705-711
124. Scherdin U., Rhodes K., and Breindl M. Transcriptionally active genome regions are preferred targets for retrovirus integration. J. Virol. 64 (1990) 907-912
125. Schliephake A.W., and Rethwilm A. Nuclear localization of foamy virus Gag precursor protein. J. Virol. 68 (1994) 4946-4954
126. Schroder A.R., Shinn P., Chen H., Berry C., Ecker J.R., and Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110 (2002) 521-529
127. Sherman M.P., and Greene W.C. Slipping through the door: HIV entry into the nucleus. Microbes. Infect. 4 (2002) 67-73
128. Shih C.C., Stoye J.P., and Coffin J.M. Highly preferred targets for retrovirus integration. Cell 53 (1988) 531-537
129. Singleton T.L., and Levin H.L. A long terminal repeat retrotransposon of fission yeast has strong preferences for specific sites of insertion. Eukaryot. Cell 1 (2002) 44-55
130. Su K., Wang D., Ye J., Kim Y.C., and Chow S.A. Site-specific integration of retroviral DNA in human cells using fusion proteins consisting of human immunodeficiency virus type 1 integrase and the designed polydactyl zinc-finger protein E2C. Methods 47 (2009) 269-276
131. Taganov K.D., Cuesta I., Daniel R., Cirillo L.A., Katz R.A., Zaret K.S., and Skalka A.M. Integrase-specific enhancement and suppression of retroviral DNA integration by compacted chromatin structure in vitro. J. Virol. 78 (2004) 5848-5855
132. Takeuchi H., and Matano T. Host factors involved in resistance to retroviral infection. Microbiol. Immunol. 52 (2008) 318-325
133. Tan W., Zhu K., Segal D.J., Barbas III C.F., and Chow S.A. Fusion proteins consisting of human immunodeficiency virus type 1 integrase and the designed polydactyl zinc finger protein E2C direct integration of viral DNA into specific sites. J. Virol. 78 (2004) 1301-1313
134. Thomas J.A., Ott D.E., and Gorelick R.J. Efficiency of human immunodeficiency virus type 1 postentry infection processes: evidence against disproportionate numbers of defective virions. J. Virol. 81 (2007) 4367-4370
135. Tobaly-Tapiero J., Bittoun P., Lehmann-Che J., Delelis O., Giron M.L., De T.H., and Saib A. Chromatin tethering of incoming foamy virus by the structural Gag protein. Traffic 9 (2008) 1717-1727
136. Trobridge G.D., Miller D.G., Jacobs M.A., Allen J.M., Kiem H.P., Kaul R., and Russell D.W. Foamy virus vector integration sites in normal human cells. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 1498-1503
137. Trono D. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J. Virol. 66 (1992) 4893-4900
138. Turlure F., Devroe E., Silver P.A., and Engelman A. Human cell proteins and human immunodeficiency virus DNA integration. Front Biosci. 9 (2004) 3187-3208
139. Van Maele B., Busschots K., Vandekerckhove L., Christ F., and Debyser Z. Cellular co-factors of HIV-1 integration. Trends Biochem. Sci. 31 (2006) 98-105
140. Vijaya S., Steffen D.L., and Robinson H.L. Acceptor sites for retroviral integrations map near DNase I-hypersensitive sites in chromatin. J. Virol. 60 (1986) 683-692
141. Wang T., Balakrishnan M., and Jonsson C.B. Major and minor groove contacts in retroviral integrase-LTR interactions. Biochemistry 38 (1999) 3624-3632
142. Withers-Ward E.S., Kitamura Y., Barnes J.P., and Coffin J.M. Distribution of targets for avian retrovirus DNA integration in vivo. Genes Dev. 8 (1994) 1473-1487
143. Woodward C.L., Prakobwanakit S., Mosessian S., and Chow S.A. Integrase interacts with nucleoporin NUP153 in mediating the nuclear import of human immunodeficiency virus type-1. J. Virol. (2009)
144. Wu X., Li Y., Crise B., and Burgess S.M. Transcription start regions in the human genome are favored targets for MLV integration. Science 300 (2003) 1749-1751
145. Wu X., Li Y., Crise B., Burgess S.M., and Munroe D.J. Weak palindromic consensus sequences are a common feature found at the integration target sites of many retroviruses. J. Virol. 79 (2005) 5211-5214
146. Xie W., Gai X., Zhu Y., Zappulla D.C., Sternglanz R., and Voytas D.F. Targeting of the yeast Ty5 retrotransposon to silent chromatin is mediated by interactions between integrase and Sir4p. Mol. Cell Biol. 21 (2001) 6606-6614
147. Yamashita M., and Emerman M. Capsid is a dominant determinant of retrovirus infectivity in nondividing cells. J. Virol. 78 (2004) 5670-5678
148. Yieh L., Hatzis H., Kassavetis G., and Sandmeyer S.B. Mutational analysis of the transcription factor IIIB-DNA target of Ty3 retroelement integration. J. Biol. Chem. 277 (2002) 25920-25928
149. Yieh L., Kassavetis G., Geiduschek E.P., and Sandmeyer S.B. The Brf and TATA-binding protein subunits of the RNA polymerase III transcription factor IIIB mediate position-specific integration of the gypsy-like element, Ty3. J. Biol. Chem. 275 (2000) 29800-29807
150. Yieh L., Kassavetis G., Geiduschek E.P., and Sandmeyer S.B. The Brf and TATA-binding protein subunits of the RNA polymerase III transcription factor IIIB mediate position-specific integration of the gypsy-like element, Ty3. J. Biol. Chem. 275 (2000) 29800-29807
151. You J., Croyle J.L., Nishimura A., Ozato K., and Howley P.M. Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117 (2004) 349-360
152. Yu S.F., Edelmann K., Strong R.K., Moebes A., Rethwilm A., and Linial M.L. The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains. J. Virol. 70 (1996) 8255-8262
153. Yu S.F., Sullivan M.D., and Linial M.L. Evidence that the human foamy virus genome is DNA. J. Virol. 73 (1999) 1565-1572
154. Zaitseva L., Cherepanov P., Leyens L., Wilson S.J., Rasaiyaah J., and Fassati A. HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome. Retrovirology 6 (2009) 11
155. Zhang H., Dornadula G., Orenstein J., and Pomerantz R.J. Morphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: evidence indicating that reverse transcription may not take place within the intact viral core. J. Hum. Virol. 3 (2000) 165-172
156. Zheng R., Jenkins T.M., and Craigie R. Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 13659-13664
157. Zhou H., Xu M., Huang Q., Gates A.T., Zhang X.D., Castle J.C., Stec E., Ferrer M., Strulovici B., Hazuda D.J., and Espeseth A.S. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host. Microbe 4 (2008) 495-504
158. Zhou Y., Zhang H., Siliciano J.D., and Siliciano R.F. Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells. J. Virol. 79 (2005) 2199-2210
159. Zhu J., and Cunningham J.M. Minus-strand DNA is present within murine type C ecotropic retroviruses prior to infection. J. Virol. 67 (1993) 2385-2388
160. Zhu Y., Zou S., Wright D.A., and Voytas D.F. Tagging chromatin with retrotransposons: target specificity of the Saccharomyces Ty5 retrotransposon changes with the chromosomal localization of Sir3p and Sir4p. Genes Dev. 13 (1999) 2738-2749
161. Zou S., and Voytas D.F. Silent chromatin determines target preference of the Saccharomyces retrotransposon Ty5. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 7412-7416
162. Zou S., Wright D.A., and Voytas D.F. The Saccharomyces Ty5 retrotransposon family is associated with origins of DNA replication at the telomeres and the silent mating locus HMR. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 920-924